advertisement
11.5.2 Topical (7)
Showing records 1 to 7
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical8945 Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocaprine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients
Kałużny JJ; Szaflik J; Czechowicz-Janicka K; Kałużny J; Orzalkiewicz A; Zaleska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
Acta Ophthalmologica Scandinavica 2003; 81: 349-
8946 Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double masked, parallel clinical trials
Zabriskie N; Netland PA
Advances in Therapy 2003; 20: 92-100
8960 Comparison of the efficacy of the fixed-combination timolol/dorzolamide versus concomitant administration of timolol and dorzolamide
Bacharach J; Delgado MF; Iwach AG
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 93-96
8959 Study on hypotensive effect of latanoprost vs timolol-dorzolamide association
Luque-Aranda R; Cabarga Del Nozal C; Silva-Silva G; Vazquez-Salvi A; Garcia-Campos JM
Archivos de la Sociedad Española de Oftalmologia 2002; 77: 205-210
8991 Effects of 5-perfluorophenyl/octyl/butyl substituted derivatives of aromatic/heterocyclic sulfonamides on carbonic anhydrase II activity in vitro and on betamethasone induced ocular hypertension in rabbits
Di Filippo C; Rossi S; Lampa E; Boldrini E; Rinaldi B; Falcone G; Mazzeo F; Filippelli W; D'Amico M
Research Communications in Pharmacology and Toxicology 2002; 7: 101-110
8990 Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side-effects
Nesher R; Ticho U
Israeli Medical Association Journal 2003; 5: 260-263
8994 Effects of twice daily application of 2% dorzolamide on intraocular pressure in normal cats
Rainbow ME; Dziezyc J
Veterinary Ophthalmology 2003; 6: 147-150
